Cargando…
Parkinson Diseases in the 2020s and Beyond: Replacing Clinico-Pathologic Convergence With Systems Biology Divergence
Parkinson disease has been considered for practical purposes a heterogeneous clinico-pathological entity. The operational definition requires clinical ascertainment of a levodopa-responsive parkinsonism with no “atypical” features, and pathological criteria based on the finding, usually at postmorte...
Autores principales: | Espay, Alberto J., Lang, Anthony E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311362/ https://www.ncbi.nlm.nih.gov/pubmed/30584155 http://dx.doi.org/10.3233/JPD-181465 |
Ejemplares similares
-
Will Artificial Intelligence Replace the Movement Disorders Specialist for Diagnosing and Managing Parkinson’s Disease?
por: Landers, Matt, et al.
Publicado: (2021) -
Convergence Insufficiency/Divergence Insufficiency Convergence Excess/Divergence Excess: Some Facts and Fictions
por: Khawam, Edward, et al.
Publicado: (2015) -
Parkinson Disease: An Evolutionary Perspective
por: Garcia-Ruiz, Pedro J., et al.
Publicado: (2017) -
Parkinson disease in Gaucher disease
por: Rodriguez-Porcel, Federico, et al.
Publicado: (2017) -
Divergence and Convergence in Enzyme Evolution
por: Galperin, Michael Y., et al.
Publicado: (2012)